Your browser doesn't support javascript.
loading
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants.
Landis, Justin T; Moorad, Razia; Pluta, Linda J; Caro-Vegas, Carolina; McNamara, Ryan P; Eason, Anthony B; Bailey, Aubrey; Villamor, Femi Cleola S; Juarez, Angelica; Wong, Jason P; Yang, Brian; Broussard, Grant S; Damania, Blossom; Dittmer, Dirk P.
Afiliação
  • Landis JT; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Moorad R; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Pluta LJ; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Caro-Vegas C; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • McNamara RP; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Eason AB; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Bailey A; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Villamor FCS; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Juarez A; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Wong JP; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Yang B; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Broussard GS; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Damania B; Kuopio Center for Gene and Cell Therapy, Kuopio, Finland.
  • Dittmer DP; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
mBio ; 14(2): e0344822, 2023 04 25.
Article em En | MEDLINE | ID: mdl-36786605
Variants of concern (VOC) in SARS-CoV-2 refer to viruses whose viral genomes differ from the ancestor virus by ≥3 single-nucleotide variants (SNVs) and that show the potential for higher transmissibility and/or worse clinical progression. VOC have the potential to disrupt ongoing public health measures and vaccine efforts. Still, too little is known regarding how frequently new viral variants emerge and under what circumstances. We report a study to determine the degree of SARS-CoV-2 sequence evolution in 94 patients and to estimate the frequency at which highly diverse variants emerge. Two cases accumulated ≥9 SNVs over a 2-week period and one case accumulated 23 SNVs over 3 weeks, including three nonsynonymous mutations in the spike protein (D138H, E554D, D614G). The remainder of the infected patients did not show signs of intra-host evolution. We estimate that in as much as 2% of hospitalized COVID-19 cases, variants with multiple mutations in the spike glycoprotein emerge in as little as 1 month of persistent intra-host virus replication. This suggests the continued local emergence of variants with multiple nonsynonymous SNVs, even in patients without overt immune deficiency. Surveillance by sequencing for (i) viremic COVID-19 patients, (ii) patients suspected of reinfection, and (iii) patients with diminished immune function may offer broad public health benefits. IMPORTANCE New SARS-CoV-2 variants can potentially disrupt ongoing public health measures and vaccine efforts. Still, little is known regarding how frequently new viral variants emerge and under what circumstances. Based on this study, we estimate that in hospitalized COVID-19 cases, variants with multiple mutations may emerge locally in as little as 1 month, even in patients without overt immune deficiency. Surveillance by sequencing for continuously shedding patients, patients suspected of reinfection, and patients with diminished immune function may offer broad public health benefits.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article